RE:RE:I Can't believe that's all !It is listed as an abstract only. No poster, no video, no floor time or presentation. The conference site lists all material that has been accepted with its available formats.
There are plenty of similar studies attesting to high specificity/sensitivity of "liquid biospy" for detecting tumour signatures. Uptake by clinicians is not driven by fancy packaging like Aristotle. Clinicians will use a product like Aristotle once independent rigorous trials turn up in high impact journals. A small abstract where all authors are paid by Stage is not a game changer for clinicians.